At least twelve major restaurant chains have introduced smaller portion sizes, higher-protein options, or dedicated "right-sized" menu sections in the first quarter of 2026, according to Nation's Restaurant News. Applebee's added four entrees under 500 calories. Darden Restaurants (Olive Garden, LongHorn) launched a protein-focused menu. Chili's reduced average portion sizes by 15 percent across its core menu. [1]
The catalyst is GLP-1 receptor agonist drugs — Ozempic, Wegovy, Mounjaro — which reduce appetite and change food preferences. An estimated 9 million Americans are now taking GLP-1 drugs. The pharmaceutical industry is reshaping the restaurant industry.
-- NORA WHITFIELD, Chicago